<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK20221" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK20221/" /><meta name="ncbi_pagename" content="ZAP70-Related Combined Immunodeficiency - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>ZAP70-Related Combined Immunodeficiency - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="ZAP70-Related Combined Immunodeficiency" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2017/06/08" /><meta name="citation_author" content="Kelly Walkovich" /><meta name="citation_author" content="Mark Vander Lugt" /><meta name="citation_pmid" content="20301777" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK20221/" /><meta name="citation_keywords" content="Tyrosine-protein kinase ZAP-70" /><meta name="citation_keywords" content="ZAP70" /><meta name="citation_keywords" content="ZAP70-Related Combined Immunodeficiency" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="ZAP70-Related Combined Immunodeficiency" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Kelly Walkovich" /><meta name="DC.Contributor" content="Mark Vander Lugt" /><meta name="DC.Date" content="2017/06/08" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK20221/" /><meta name="description" content="ZAP70-related combined immunodeficiency (ZAP70-related CID) is a cell-mediated immunodeficiency caused by abnormal T-cell receptor (TCR) signaling. Affected children usually present in the first year of life with recurrent bacterial, viral, and opportunistic infections, diarrhea, and failure to thrive. Severe lower-respiratory infections and oral candidiasis are common. Affected children usually do not survive past their second year without hematopoietic stem cell transplantation (HSCT)." /><meta name="og:title" content="ZAP70-Related Combined Immunodeficiency" /><meta name="og:type" content="book" /><meta name="og:description" content="ZAP70-related combined immunodeficiency (ZAP70-related CID) is a cell-mediated immunodeficiency caused by abnormal T-cell receptor (TCR) signaling. Affected children usually present in the first year of life with recurrent bacterial, viral, and opportunistic infections, diarrhea, and failure to thrive. Severe lower-respiratory infections and oral candidiasis are common. Affected children usually do not survive past their second year without hematopoietic stem cell transplantation (HSCT)." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK20221/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/zap70-scid/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK20221/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8B8FB8E04104310000000000B10038.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK20221_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK20221_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/yci/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/pbd/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK20221_"><span class="title" itemprop="name"><i>ZAP70</i>-Related Combined Immunodeficiency</span></h1><p class="contrib-group"><span itemprop="author">Kelly Walkovich</span>, MD and <span itemprop="author">Mark Vander Lugt</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK20221_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK20221_ai__"><div class="contrib half_rhythm"><span itemprop="author">Kelly Walkovich</span>, MD<div class="affiliation small">University of Michigan Medical School<br />Ann Arbor, Michigan<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.hcimu.dem@ivoklawk" class="oemail">ude.hcimu.dem@ivoklawk</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Mark Vander Lugt</span>, MD<div class="affiliation small">University of Michigan Medical School<br />Ann Arbor, Michigan<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.hcimu.dem@ednavram" class="oemail">ude.hcimu.dem@ednavram</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">October 20, 2009</span>; Last Update: <span itemprop="dateModified">June 8, 2017</span>.</p><p><em>Estimated reading time: 21 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="zap70-scid.Summary" itemprop="description"><h2 id="_zap70-scid_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>ZAP70</i>-related combined immunodeficiency (<i>ZAP70</i>-related CID) is a cell-mediated immunodeficiency caused by abnormal T-cell receptor (TCR) signaling. Affected children usually present in the first year of life with recurrent bacterial, viral, and opportunistic infections, diarrhea, and failure to thrive. Severe lower-respiratory infections and oral candidiasis are common. Affected children usually do not survive past their second year without hematopoietic stem cell transplantation (HSCT).</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of <i>ZAP70</i>-related CID is suggested by low to absent CD8<sup>+</sup> T cells in an individual with normal CD3+ and CD4+ T-cell counts. Additional supportive laboratory features include absent proliferation of CD4<sup>+</sup> T cells in response to mitogens and antigens, and absent ZAP-70 protein expression. The diagnosis is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>ZAP70</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Supportive care includes immediate intravenous immunoglobulin (IVIG) and antibacterial, antifungal, antiviral, and <i>Pneumocystis</i>
<i>jiroveci</i> prophylaxis to control and reduce the occurrence of infections.</p><p><i>Prevention of primary manifestations:</i> Allogeneic HSCT to reconstitute the immune system, preferably prior to the onset of infections.</p><p><i>Prevention of secondary complications:</i> Use of irradiated, leukoreduced, cytomegalovirus (CMV)-safe blood products; deferment of immunizations until immune reconstitution; consideration for formula feeds in place of breast feeding until CMV status of mother is known.</p><p><i>Surveillance:</i> Individuals with milder findings or those who have not undergone HSCT need to be monitored for worsening of immune function with periodic assessment of clinical status and functional lymphocyte responsiveness. Following a successful HSCT, the following should be routinely monitored: growth, psychomotor development, complete blood counts, liver and renal function, immune status, donor and recipient chimerism, development of post-transplant complications.</p><p><i>Agents/circumstances to avoid:</i> Non-irradiated blood products; live viral, live mycobacterial, and live bacterial vaccinations; contaminated water sources; exposure to fungus-enriched environments (e.g., construction sites, agricultural areas with active soil disruption, mulch, hay).</p><p><i>Evaluation of relatives at risk:</i> Because the outcome of HSCT in children with <i>ZAP70</i>-related CID is significantly improved by performing HSCT prior to the onset of severe infections, early testing of at-risk sibs should be considered. In addition, any sibs considered as bone marrow donors must be evaluated for <i>ZAP70</i>-related CID prior to donation.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>ZAP70</i>-related CID is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk family members and <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for pregnancies at increased risk are possible if the pathogenic variants in the family are known.</p></div></div><div id="zap70-scid.Diagnosis"><h2 id="_zap70-scid_Diagnosis_">Diagnosis</h2><div id="zap70-scid.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>ZAP70</i>-related combined immunodeficiency (<i>ZAP70</i>-related CID) <b>should be suspected</b> in individuals who present with the following findings within the first two years of life:</p><ul><li class="half_rhythm"><div>Recurrent viral, bacterial, and opportunistic infections</div></li><li class="half_rhythm"><div>Chronic diarrhea and failure to thrive</div></li><li class="half_rhythm"><div>Characteristic results of lymphocyte subset analysis of CD3, CD4, and CD8 T cells, lymphocyte functional testing, and ZAP-70 protein expression (see <b>Lymphocyte development and numbers</b>)</div></li></ul><p>Note: Individuals with non-classic <i>ZAP70</i>-related CID may present at an older age with symptoms of autoimmunity, lymphoproliferation, and/or immune dysregulation with or without evidence of immunodeficiency.</p><p><b>Lymphocyte development and numbers.</b> In <i>ZAP70</i>-related CID, total lymphocyte counts can range from normal to high.</p><ul><li class="half_rhythm"><div>Thymic architecture is largely preserved in individuals with <i>ZAP70</i>-related CID; however, compared to controls, a smaller medullary zone, decreased numbers of AIRE+ medullary thymic epithelial cells, and decreased numbers of dendritic cell numbers may be seen [<a class="bk_pop" href="#zap70-scid.REF.poliani.2013">Poliani et al 2013</a>].</div></li><li class="half_rhythm"><div>T-cell counts:</div><ul><li class="half_rhythm"><div>CD3<sup>+</sup> cell counts are typically normal.</div></li><li class="half_rhythm"><div>CD4<sup>+</sup> cell counts are normal or elevated and may account for 60%-80% of the lymphocytes in individuals with <i>ZAP70</i>-related CID. Numbers of CD4+ recent thymic emigrants may be decreased [<a class="bk_pop" href="#zap70-scid.REF.hauck.2015.103">Hauck et al 2015</a>].</div></li><li class="half_rhythm"><div>CD8<sup>+</sup> cells are absent or extremely low, often comprising only 0%-2% of the child's total T-cell count in individuals with <i>ZAP70</i>-related CID [<a class="bk_pop" href="#zap70-scid.REF.arpaia.1994.947">Arpaia et al 1994</a>, <a class="bk_pop" href="#zap70-scid.REF.noraz.2000.15832">Noraz et al 2000</a>].</div></li><li class="half_rhythm"><div>Numbers of regulatory T cells may be normal or decreased [<a class="bk_pop" href="#zap70-scid.REF.poliani.2013">Poliani et al 2013</a>, <a class="bk_pop" href="#zap70-scid.REF.hauck.2015.103">Hauck et al 2015</a>].</div></li></ul></li><li class="half_rhythm"><div>B cell counts and NK cell counts are normal.</div></li></ul><p><b>Lymphocyte function.</b> T-cell responses to stimuli that act through the T-cell receptor (TCR) are absent or severely diminished:</p><ul><li class="half_rhythm"><div>Absent or decreased proliferation to CD3 antibody [<a class="bk_pop" href="#zap70-scid.REF.roifman.2010.1226">Roifman et al 2010</a>]</div></li><li class="half_rhythm"><div>Absent or decreased proliferation of CD4<sup>+</sup> cells in response to mitogens (e.g., PHA, ConA) [<a class="bk_pop" href="#zap70-scid.REF.roifman.2012.177">Roifman et al 2012</a>]</div></li><li class="half_rhythm"><div>Intact proliferative response to mitogenic stimuli that bypass the TCR (e.g., PMA/Ionomycin) [<a class="bk_pop" href="#zap70-scid.REF.elder.1994.1596">Elder et al 1994</a>, <a class="bk_pop" href="#zap70-scid.REF.elder.1997.546">Elder 1997</a>]</div></li><li class="half_rhythm"><div>Normal TCR V&#x003b2; repertoire in both CD4+ and CD8+ T cells [<a class="bk_pop" href="#zap70-scid.REF.roifman.2010.1226">Roifman et al 2010</a>]</div></li><li class="half_rhythm"><div>In CD4 cells: limited differentiation into Th2 cells and resistance to Fas-induced cell death [<a class="bk_pop" href="#zap70-scid.REF.roifman.2010.1226">Roifman et al 2010</a>]</div></li><li class="half_rhythm"><div>In regulatory T cells: potentially decreased expression of <i>CTLA4</i> and <i>TGFB</i> leading to increased risk of autoimmunity [<a class="bk_pop" href="#zap70-scid.REF.roifman.2010.1226">Roifman et al 2010</a>]</div></li></ul><p><b>ZAP-70 protein expression.</b> Testing of CD4<sup>+</sup> T cells reveals absence or near absence of ZAP-70 protein in most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Recent reports suggest that the amount of residual ZAP-70 protein expression influences the clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#zap70-scid.REF.picard.2009.1966">Picard et al 2009</a>, <a class="bk_pop" href="#zap70-scid.REF.chan.2016.155">Chan et al 2016</a>, <a class="bk_pop" href="#zap70-scid.REF.gavino.2017.1688">Gavino et al 2017</a>]. Expression of Syk, a related tyrosine kinase important in T-cell signaling, may partially compensate for ZAP-70 signaling in some individuals [<a class="bk_pop" href="#zap70-scid.REF.toyabe.2001.164">Toyabe et al 2001</a>, <a class="bk_pop" href="#zap70-scid.REF.hauck.2015.103">Hauck et al 2015</a>].</p><p><b>Immunoglobulin concentrations and function</b></p><ul><li class="half_rhythm"><div>Immunoglobulin levels vary by individual. Many <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have severe hypogammaglobulinemia, but normal immunoglobulins or elevated IgA, IgM, and/or IgE can also be seen [<a class="bk_pop" href="#zap70-scid.REF.turul.2009.87">Turul et al 2009</a>, <a class="bk_pop" href="#zap70-scid.REF.cuvelier.2016.713">Cuvelier et al 2016</a>].</div></li><li class="half_rhythm"><div>Although functional antibody responses to immunization are present in a few persons [<a class="bk_pop" href="#zap70-scid.REF.turul.2009.87">Turul et al 2009</a>, <a class="bk_pop" href="#zap70-scid.REF.hauck.2015.103">Hauck et al 2015</a>], this finding does not indicate that all specific antigenic responses are intact.</div></li></ul><p><b>Newborn screening.</b> The utility of TREC screening for individuals with <i>ZAP70</i>-related CID continues to be controversial. Although some have shown that TREC levels in individuals with confirmed <i>ZAP70</i>-related CID are very low compared to age-matched controls [<a class="bk_pop" href="#zap70-scid.REF.roifman.2010.1226">Roifman et al 2010</a>, <a class="bk_pop" href="#zap70-scid.REF.roifman.2012.177">Roifman et al 2012</a>, <a class="bk_pop" href="#zap70-scid.REF.aluri.2017.95">Aluri et al 2017</a>], others have shown that a substantial portion of individuals with <i>ZAP70</i>-related CID have TREC levels above the cutoffs used for <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> and could be missed [<a class="bk_pop" href="#zap70-scid.REF.grazioli.2014.209">Grazioli et al 2014</a>, <a class="bk_pop" href="#zap70-scid.REF.jilkina.2014.324">Jilkina et al 2014</a>, <a class="bk_pop" href="#zap70-scid.REF.hauck.2015.103">Hauck et al 2015</a>, <a class="bk_pop" href="#zap70-scid.REF.schroeder.2016.50">Schroeder et al 2016</a>]. Therefore, newborn screening results must be interpreted with caution in individuals with clinical findings consistent with <i>ZAP70</i>-related CID or in populations with a high prevalence of <i>ZAP70</i>-related CID.</p></div><div id="zap70-scid.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of <i>ZAP70</i>-related CID <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>ZAP70</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK20221/table/zap70-scid.T.molecular_genetic_testing_u/?report=objectonly" target="object" rid-figpopup="figzap70scidTmoleculargenetictestingu" rid-ob="figobzap70scidTmoleculargenetictestingu">Table 1</a>).</p><p>Molecular genetic testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>ZAP70</i> is performed.</div><div class="half_rhythm">Note: (1) No deletions or duplications of <i>ZAP70</i> have been reported. (2) Targeted analysis for the c.1624-11G&#x0003e;A variant can be performed first in individuals of Mennonite ancestry.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>ZAP70</i> and other genes of interest (see <a href="#zap70-scid.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered.</div><div class="half_rhythm">Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> varies by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div id="zap70-scid.T.molecular_genetic_testing_u" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>ZAP70</i>-Related Combined Immunodeficiency</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK20221/table/zap70-scid.T.molecular_genetic_testing_u/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__zap70-scid.T.molecular_genetic_testing_u_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_zap70-scid.T.molecular_genetic_testing_u_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_zap70-scid.T.molecular_genetic_testing_u_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_zap70-scid.T.molecular_genetic_testing_u_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_zap70-scid.T.molecular_genetic_testing_u_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>ZAP70</i></td><td headers="hd_h_zap70-scid.T.molecular_genetic_testing_u_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_zap70-scid.T.molecular_genetic_testing_u_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">44/44&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_zap70-scid.T.molecular_genetic_testing_u_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_zap70-scid.T.molecular_genetic_testing_u_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="zap70-scid.TF.1.1"><p class="no_margin">See <a href="/books/NBK20221/#zap70-scid.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="zap70-scid.TF.1.2"><p class="no_margin">See <a href="#zap70-scid.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="zap70-scid.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="zap70-scid.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#zap70-scid.REF.arpaia.1994.947">Arpaia et al [1994]</a>, <a class="bk_pop" href="#zap70-scid.REF.chan.1994.1599">Chan et al [1994]</a>, <a class="bk_pop" href="#zap70-scid.REF.elder.1994.1596">Elder et al [1994]</a>, <a class="bk_pop" href="#zap70-scid.REF.matsuda.1999.34515">Matsuda et al [1999]</a>, <a class="bk_pop" href="#zap70-scid.REF.meinl.2000.3578">Meinl et al [2000]</a>, <a class="bk_pop" href="#zap70-scid.REF.noraz.2000.15832">Noraz et al [2000]</a>, <a class="bk_pop" href="#zap70-scid.REF.barata.2001.413">Barata et al [2001]</a>, <a class="bk_pop" href="#zap70-scid.REF.elder.2001.656">Elder et al [2001]</a>, <a class="bk_pop" href="#zap70-scid.REF.toyabe.2001.164">Toyabe et al [2001]</a>, <a class="bk_pop" href="#zap70-scid.REF.fagioli.2003.133">Fagioli et al [2003]</a>, <a class="bk_pop" href="#zap70-scid.REF.picard.2009.1966">Picard et al [2009]</a>, <a class="bk_pop" href="#zap70-scid.REF.turul.2009.87">Turul et al [2009]</a>, <a class="bk_pop" href="#zap70-scid.REF.santos.2010.530">Santos et al [2010]</a>, <a class="bk_pop" href="#zap70-scid.REF.newell.2011.517">Newell et al [2011]</a>, <a class="bk_pop" href="#zap70-scid.REF.h_nig.2012.305">H&#x000f6;nig et al [2012]</a>, <a class="bk_pop" href="#zap70-scid.REF.roifman.2012.177">Roifman et al [2012]</a>, <a class="bk_pop" href="#zap70-scid.REF.karaca.2013.189">Karaca et al [2013]</a>, <a class="bk_pop" href="#zap70-scid.REF.kim.2013.1233">Kim et al [2013]</a>, <a class="bk_pop" href="#zap70-scid.REF.grazioli.2014.209">Grazioli et al [2014]</a>, <a class="bk_pop" href="#zap70-scid.REF.akar.2015.88">Akar et al [2015]</a>, <a class="bk_pop" href="#zap70-scid.REF.hauck.2015.103">Hauck et al [2015]</a>, <a class="bk_pop" href="#zap70-scid.REF.cuvelier.2016.713">Cuvelier et al [2016]</a>, <a class="bk_pop" href="#zap70-scid.REF.esenboga.2016.103">Esenboga et al [2016]</a>, <a class="bk_pop" href="#zap70-scid.REF.schroeder.2016.50">Schroeder et al [2016]</a>, <a class="bk_pop" href="#zap70-scid.REF.aluri.2017.95">Aluri et al [2017]</a>, <a class="bk_pop" href="#zap70-scid.REF.gavino.2017.1688">Gavino et al [2017]</a>, <a class="bk_pop" href="#zap70-scid.REF.shirkani.2017.70">Shirkani et al [2017]</a></p></div></dd><dt>5. </dt><dd><div id="zap70-scid.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="zap70-scid.TF.1.6"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd></dl></div></div></div></div></div><div id="zap70-scid.Clinical_Characteristics"><h2 id="_zap70-scid_Clinical_Characteristics_">Clinical Characteristics</h2><div id="zap70-scid.Clinical_Description"><h3>Clinical Description</h3><p>Individuals with <i>ZAP70</i>-related CID characteristically present in the first two years of life with recurrent bacterial, viral (including live-virus vaccine strains), and opportunistic infections, diarrhea, and failure to thrive. Severe lower-respiratory infections are seen, most notably <i>Pneumocystis jiroveci</i> infections and viral infections. Oral candidiasis is also common [<a class="bk_pop" href="#zap70-scid.REF.cuvelier.2016.713">Cuvelier et al 2016</a>, <a class="bk_pop" href="#zap70-scid.REF.schroeder.2016.50">Schroeder et al 2016</a>].</p><p>Other presentations have also been reported:</p><ul><li class="half_rhythm"><div>Reports of milder phenotypes in sibs of children who had died from <i>ZAP70</i>-related CID include a child age five months with recurrent lower-respiratory disease but no severe infections [<a class="bk_pop" href="#zap70-scid.REF.turul.2009.87">Turul et al 2009</a>] and a child with persistent dermatitis resistant to therapy [<a class="bk_pop" href="#zap70-scid.REF.katamura.1999.124">Katamura et al 1999</a>].</div></li><li class="half_rhythm"><div>A child age nine years with a <i>ZAP70</i> <a class="def" href="/books/n/gene/glossary/def-item/hypomorphic/">hypomorphic</a> <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> had an attenuated clinical and immunologic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#zap70-scid.REF.picard.2009.1966">Picard et al 2009</a>] (see <a href="#zap70-scid.GenotypePhenotype_Correlation">Genotype-Phenotype Correlations</a>).</div></li><li class="half_rhythm"><div>A child age 11 months with <i>ZAP70</i>-related CID presented with lymphoma [<a class="bk_pop" href="#zap70-scid.REF.newell.2011.517">Newell et al 2011</a>].</div></li><li class="half_rhythm"><div>BCG-related complications including axillary lymphadenitis or disseminated mycobacterial disease following BCG vaccination may be presenting features [<a class="bk_pop" href="#zap70-scid.REF.santos.2010.530">Santos et al 2010</a>, <a class="bk_pop" href="#zap70-scid.REF.esenboga.2016.103">Esenboga et al 2016</a>].</div></li><li class="half_rhythm"><div>Two individuals presented with recurrent infections and silent brain infarcts; one also had <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> nephrotic syndrome and autoimmune hemolytic anemia [<a class="bk_pop" href="#zap70-scid.REF.akar.2015.88">Akar et al 2015</a>].</div></li><li class="half_rhythm"><div>An individual with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> treatment-refractory immune thrombocytopenia (ITP) has been described [<a class="bk_pop" href="#zap70-scid.REF.cuvelier.2016.713">Cuvelier et al 2016</a>].</div></li><li class="half_rhythm"><div>Two sibs had refractory autoimmune features including nephrotic syndrome/proteinuria, bullous pemphigoid, and colitis; one also developed autoantibodies to factor VIII caused by a <a class="def" href="/books/n/gene/glossary/def-item/hypomorphic/">hypomorphic</a> and weakly activating <i>ZAP70</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#zap70-scid.REF.chan.2016.155">Chan et al 2016</a>].</div></li><li class="half_rhythm"><div>An adult with a history of infantile-onset colitis, recurrent respiratory-tract infections, mucocutaneous candidiasis, HSV stomatitis, VZV infection, EBV lymphoproliferative disorder, recurrent CMV viremia, polyomaviremia, and epidermodysplasia verruciformis-like lesions due to HHV-23 was recently reported. A novel <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (<a class="figpopup" href="/books/NBK20221/table/zap70-scid.T.zap70_pathogenic_variants_d/?report=objectonly" target="object" rid-figpopup="figzap70scidTzap70pathogenicvariantsd" rid-ob="figobzap70scidTzap70pathogenicvariantsd">c.1272C&#x0003e;T</a>) that leads to an altered <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> and low levels of <a class="def" href="/books/n/gene/glossary/def-item/wild-type/">wild-type</a> ZAP-70 protein was identified in this individual [<a class="bk_pop" href="#zap70-scid.REF.gavino.2017.1688">Gavino et al 2017</a>].</div></li></ul><p>The long-term prognosis of untreated <i>ZAP70</i>-related CID is death from infection. Affected children have a declining quality of life and usually do not survive past their second year without hematopoietic stem cell transplantation (HSCT).</p></div><div id="zap70-scid.GenotypePhenotype_Correlation"><h3>Genotype-Phenotype Correlations</h3><p>There is very little <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation reported in <i>ZAP70</i>-related CID; however, the amount of residual ZAP-70 protein expressed may modulate the clinical phenotype, as suggested by the following:</p><ul><li class="half_rhythm"><div>A child with a <a class="def" href="/books/n/gene/glossary/def-item/hypomorphic/">hypomorphic</a> <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (<a class="figpopup" href="/books/NBK20221/table/zap70-scid.T.zap70_pathogenic_variants_d/?report=objectonly" target="object" rid-figpopup="figzap70scidTzap70pathogenicvariantsd" rid-ob="figobzap70scidTzap70pathogenicvariantsd">c.837+121G&#x0003e;A</a> in <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 7) who had had chronic eczema from age two months and recurrent infections from age two years. The frequency of infections declined at age six following introduction of co-trimoxazole and IVIG prophylaxis. Of note, an older sib with a history of multiple infections had died at age one year [<a class="bk_pop" href="#zap70-scid.REF.picard.2009.1966">Picard et al 2009</a>].</div></li><li class="half_rhythm"><div>Two sibs with refractory autoimmune features including nephrotic syndrome/proteinuria, bullous pemphigoid, and colitis. One sib also developed autoantibodies to factor VIII. These sibs had <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> <i>ZAP70</i> pathogenic variants including a <a class="def" href="/books/n/gene/glossary/def-item/hypomorphic/">hypomorphic</a> variant (<a class="figpopup" href="/books/NBK20221/table/zap70-scid.T.zap70_pathogenic_variants_d/?report=objectonly" target="object" rid-figpopup="figzap70scidTzap70pathogenicvariantsd" rid-ob="figobzap70scidTzap70pathogenicvariantsd">c.574C&#x0003e;T</a>) and a weakly activating variant (<a class="figpopup" href="/books/NBK20221/table/zap70-scid.T.zap70_pathogenic_variants_d/?report=objectonly" target="object" rid-figpopup="figzap70scidTzap70pathogenicvariantsd" rid-ob="figobzap70scidTzap70pathogenicvariantsd">c.1079G&#x0003e;C</a>) [<a class="bk_pop" href="#zap70-scid.REF.chan.2016.155">Chan et al 2016</a>].</div></li></ul></div><div id="zap70-scid.Nomenclature"><h3>Nomenclature</h3><p><i>ZAP70</i>-related combined immunodeficiency may also be referred to as zeta-associated protein 70 deficiency or immunodeficiency 48.</p></div><div id="zap70-scid.Prevalence"><h3>Prevalence</h3><p><i>ZAP70</i>-related CID was first described in 1994 in three individuals of Mennonite descent [<a class="bk_pop" href="#zap70-scid.REF.arpaia.1994.947">Arpaia et al 1994</a>]. Since that time, more than 50 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have been described in the literature [<a class="bk_pop" href="#zap70-scid.REF.arpaia.1994.947">Arpaia et al 1994</a>, <a class="bk_pop" href="#zap70-scid.REF.chan.1994.1599">Chan et al 1994</a>, <a class="bk_pop" href="#zap70-scid.REF.elder.1994.1596">Elder et al 1994</a>, <a class="bk_pop" href="#zap70-scid.REF.elder.1995.110">Elder et al 1995</a>, <a class="bk_pop" href="#zap70-scid.REF.gelfand.1995.1057">Gelfand et al 1995</a>, <a class="bk_pop" href="#zap70-scid.REF.katamura.1999.124">Katamura et al 1999</a>, <a class="bk_pop" href="#zap70-scid.REF.matsuda.1999.34515">Matsuda et al 1999</a>, <a class="bk_pop" href="#zap70-scid.REF.meinl.2000.3578">Meinl et al 2000</a>, <a class="bk_pop" href="#zap70-scid.REF.noraz.2000.15832">Noraz et al 2000</a>, <a class="bk_pop" href="#zap70-scid.REF.barata.2001.413">Barata et al 2001</a>, <a class="bk_pop" href="#zap70-scid.REF.elder.2001.656">Elder et al 2001</a>, <a class="bk_pop" href="#zap70-scid.REF.toyabe.2001.164">Toyabe et al 2001</a>, <a class="bk_pop" href="#zap70-scid.REF.fagioli.2003.133">Fagioli et al 2003</a>, <a class="bk_pop" href="#zap70-scid.REF.picard.2009.1966">Picard et al 2009</a>, <a class="bk_pop" href="#zap70-scid.REF.turul.2009.87">Turul et al 2009</a>, <a class="bk_pop" href="#zap70-scid.REF.santos.2010.530">Santos et al 2010</a>, <a class="bk_pop" href="#zap70-scid.REF.newell.2011.517">Newell et al 2011</a>, <a class="bk_pop" href="#zap70-scid.REF.h_nig.2012.305">H&#x000f6;nig et al 2012</a>, <a class="bk_pop" href="#zap70-scid.REF.roifman.2012.177">Roifman et al 2012</a>, <a class="bk_pop" href="#zap70-scid.REF.karaca.2013.189">Karaca et al 2013</a>, <a class="bk_pop" href="#zap70-scid.REF.kim.2013.1233">Kim et al 2013</a>, <a class="bk_pop" href="#zap70-scid.REF.grazioli.2014.209">Grazioli et al 2014</a>, <a class="bk_pop" href="#zap70-scid.REF.akar.2015.88">Akar et al 2015</a>, <a class="bk_pop" href="#zap70-scid.REF.hauck.2015.103">Hauck et al 2015</a>, <a class="bk_pop" href="#zap70-scid.REF.cuvelier.2016.713">Cuvelier et al 2016</a>, <a class="bk_pop" href="#zap70-scid.REF.esenboga.2016.103">Esenboga et al 2016</a>, <a class="bk_pop" href="#zap70-scid.REF.schroeder.2016.50">Schroeder et al 2016</a>, <a class="bk_pop" href="#zap70-scid.REF.aluri.2017.95">Aluri et al 2017</a>, <a class="bk_pop" href="#zap70-scid.REF.gavino.2017.1688">Gavino et al 2017</a>, <a class="bk_pop" href="#zap70-scid.REF.shirkani.2017.70">Shirkani et al 2017</a>].</p><p>The prevalence of <i>ZAP70</i>-related CID is unknown but much lower than that of all forms of SCID, which is estimated at 1:50,000. Prevalence is higher in the Canadian Mennonite population, where a <a class="figpopup" href="/books/NBK20221/table/zap70-scid.T.zap70_pathogenic_variants_d/?report=objectonly" target="object" rid-figpopup="figzap70scidTzap70pathogenicvariantsd" rid-ob="figobzap70scidTzap70pathogenicvariantsd">c.1624-11G&#x0003e;A</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> resulting in destabilization of the ZAP-70 protein is frequently seen [<a class="bk_pop" href="#zap70-scid.REF.arpaia.1994.947">Arpaia et al 1994</a>, <a class="bk_pop" href="#zap70-scid.REF.jilkina.2014.324">Jilkina et al 2014</a>, <a class="bk_pop" href="#zap70-scid.REF.cuvelier.2016.713">Cuvelier et al 2016</a>, <a class="bk_pop" href="#zap70-scid.REF.schroeder.2016.50">Schroeder et al 2016</a>].</p></div></div><div id="zap70-scid.Genetically_Related_Allelic_D"><h2 id="_zap70-scid_Genetically_Related_Allelic_D_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>ZAP70</i>.</p></div><div id="zap70-scid.Differential_Diagnosis"><h2 id="_zap70-scid_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Human immunodeficiency virus infection.</b> Infants positive for human immunodeficiency virus (HIV+) may present with recurring infections and failure to thrive similar to CID. Individuals with HIV have CD4<sup>+</sup> lymphopenia, in contrast to the CD8<sup>+</sup> lymphopenia in individuals with <i>ZAP70</i>-related CID. In a neonate, the definitive diagnosis of HIV should be made by detection of cell-associated human immunodeficiency proviral DNA by <a class="def" href="/books/n/gene/glossary/def-item/polymerase-chain-reaction/">polymerase chain reaction</a> (<a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a>) amplification. See <a class="figpopup" href="/books/NBK20221/table/zap70-scid.T.combined_immunodeficiencies/?report=objectonly" target="object" rid-figpopup="figzap70scidTcombinedimmunodeficiencies" rid-ob="figobzap70scidTcombinedimmunodeficiencies">Table 2</a> for additional considerations.</p><div id="zap70-scid.T.combined_immunodeficiencies" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Combined Immunodeficiencies in the Differential Diagnosis of <i>ZAP70</i>-Related CID</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK20221/table/zap70-scid.T.combined_immunodeficiencies/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__zap70-scid.T.combined_immunodeficiencies_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene Involved</th><th id="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_3" style="text-align:left;vertical-align:middle;">Mode of<br />Inheritance</th><th id="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_4" colspan="4" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Lymphocyte Phenotype</th></tr><tr><th headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_4" id="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">T</th><th headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_4" id="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">B</th><th headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_4" id="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NK</th><th headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_4" id="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_2_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Other</th></tr></thead><tbody><tr><td headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ZAP70</i>-related CID</td><td headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ZAP70</i></td><td headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_4 hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_4 hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_4 hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_4 hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CD4<sup>+</sup>/CD8<sup>-</sup></td></tr><tr><td headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Familial CD8 deficiency</td><td headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CD8A</i></td><td headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_4 hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_4 hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_4 hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_4 hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CD4<sup>+</sup>/CD8<sup>&#x02013;</sup></td></tr><tr><td headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CD25 deficiency</td><td headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>IL2RA</i></td><td headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_4 hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_4 hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_4 hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_4 hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CD4<sup>&#x02013;</sup>/CD8<sup>+</sup></td></tr><tr><td headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MHC II deficiency (BLS)</td><td headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See <b>Major histocompatibility complex class II deficiency</b></td><td headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_4 hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_4 hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_4 hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_1_4 hd_h_zap70-scid.T.combined_immunodeficiencies_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CD4<sup>&#x02013;</sup>/CD8<sup>+</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">BLS = bare lymphocyte syndrome; MHC II = major histocompatibility complex class II</p></div></dd></dl></div></div></div><p><b>Familial CD8 deficiency</b> (OMIM <a href="http://omim.org/entry/608957" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">608957</a>) may have a presentation similar to <i>ZAP70</i>-related CID; the diagnosis can be confirmed with <i>CD8A</i> <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. The two individuals reported with this disease had recurring infections from early childhood and lived past their twenties [<a class="bk_pop" href="#zap70-scid.REF.de_la_callemartin.2001.117">de la Calle-Martin et al 2001</a>, <a class="bk_pop" href="#zap70-scid.REF.mancebo.2008.479">Mancebo et al 2008</a>].</p><p><b>CD25 deficiency</b> (OMIM <a href="http://omim.org/entry/606367" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">606367</a>) also presents with recurring infections early in life with low to normal T-cell counts. However, the T cells are CD4<sup>&#x02013;</sup>/CD8<sup>+</sup>. The diagnosis can be confirmed with <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of <i>IL2RA</i> (<i>CD25</i>), which encodes the interleukin-2 receptor alpha chain.</p><p><b>Major histocompatibility complex (MHC) class II deficiency</b> (also known as bare lymphocyte syndrome) (OMIM <a href="http://omim.org/entry/209920" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">209920</a>) may have normal or elevated T-cell counts; however, the T cells are CD4<sup>&#x02013;</sup>/CD8<sup>+</sup>. As in other forms of CID, pathologic findings manifest within the first year of life. Major histocompatibility complex II expression is decreased. Molecular genetic testing may reveal pathogenic variants in <i>RFX5</i>, <i>RFXAP</i>, <i>CIITA</i>, or <i>RFXANK</i>, the four genes in which pathogenic variants are known to cause this disorder.</p><p><a class="figpopup" href="/books/NBK20221/table/zap70-scid.T.tcellnegative_forms_of_cid/?report=objectonly" target="object" rid-figpopup="figzap70scidTtcellnegativeformsofcid" rid-ob="figobzap70scidTtcellnegativeformsofcid">Table 3</a> differentiates several forms of combined immunodeficiency. Since CID presents as a phenotypically heterogeneous class of diseases, it is useful to recognize forms that present with low to normal T-cell counts. Lymphocyte subset testing and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can implicate or rule out these other forms of CID.</p><div id="zap70-scid.T.tcellnegative_forms_of_cid" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>T-Cell-Negative Forms of CID in the Differential Diagnosis of <i>ZAP70</i>-Related CID</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK20221/table/zap70-scid.T.tcellnegative_forms_of_cid/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__zap70-scid.T.tcellnegative_forms_of_cid_lrgtbl__"><table><thead><tr><th id="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s) Involved</th><th id="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_3" style="text-align:left;vertical-align:middle;">Mode of<br />Inheritance</th><th id="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_4" rowspan="2" scope="col" colspan="1" headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_4" style="text-align:left;vertical-align:middle;">Defect</th><th id="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_5" colspan="3" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Lymphocyte Phenotype</th></tr><tr><th headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_5" id="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">T</th><th headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_5" id="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">B</th><th headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_5" id="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NK</th></tr></thead><tbody><tr><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ZAP70</i>-related CID</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ZAP70</i></td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_4" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;">Decreased protein expression</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_5 hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_5 hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_5 hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td></tr><tr><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>JAK3</i>-related SCID (OMIM <a href="http://omim.org/entry/600802" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">600802</a>)</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>JAK3</i></td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_5 hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_2_1" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_5 hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_5 hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td></tr><tr><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>IL7R</i>-related SCID (OMIM <a href="http://omim.org/entry/608971" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">608971</a>)</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>IL7R</i></td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_5 hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_2_1" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_5 hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_5 hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td></tr><tr><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CD45 deficiency (OMIM <a href="https://omim.org/entry/608971" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">608971</a>)</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PTPRC</i></td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_5 hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_2_1" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_5 hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_5 hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td></tr><tr><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/ada/">ADA deficiency</a></td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ADA</i></td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_4" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;">Decreased protein production</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_5 hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_5 hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_5 hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td></tr><tr><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">RAG1/2 deficiency (OMIIM <a href="https://omim.org/entry/601457" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">601457</a>)</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RAG1</i>, <i>RAG2</i></td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_5 hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_2_1" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_5 hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_5 hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td></tr><tr><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SCID Athabascan (OMIM <a href="https://omim.org/entry/602450" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">602450</a>)</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DCLRE1C</i></td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_5 hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_2_1" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_5 hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_5 hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td></tr><tr><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/x-scid/">X-linked SCID</a></td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>IL2RG</i></td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dysfunctional receptor</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_5 hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_5 hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_1_5 hd_h_zap70-scid.T.tcellnegative_forms_of_cid_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td></tr></tbody></table></div></div><p><b>Omenn syndrome</b> (OMIM <a href="http://omim.org/entry/603554" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">603554</a>). Some individuals with <i>ZAP70</i>-related CID can present with Omenn syndrome-like features including rash, lymphadenopathy, hepatosplenomegaly, and eosinophilia.</p></div><div id="zap70-scid.Management"><h2 id="_zap70-scid_Management_">Management</h2><div id="zap70-scid.Evaluations_Following_Initial"><h3>Evaluations Following Initial Diagnosis</h3><p>The care of individuals diagnosed with <i>ZAP70</i>-related CID is best managed with a multidisciplinary team of providers including hematology/oncology/bone marrow transplantation, immunology, genetics, and infectious disease specialists. To establish the extent of disease and needs in an individual diagnosed with <i>ZAP70</i>-related combined immunodeficiency (CID), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Assessment of growth</div></li><li class="half_rhythm"><div>Evaluation for common and opportunistic viral, bacterial, and fungal disease-causing agents</div></li><li class="half_rhythm"><div>Complete metabolic panel (liver and renal function), complete blood count (CBC) with differential and platelet count, lymphocyte subsets and mitogen proliferation, and quantitative immunoglobulins</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li><li class="half_rhythm"><div>Consultation with a clinical immunologist</div></li><li class="half_rhythm"><div>Consultation for hematopoietic stem cell transplantation</div></li></ul></div><div id="zap70-scid.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Treatment relies on prompt reconstitution of the individual's immune system (see <a href="#zap70-scid.Prevention_of_Primary_Manifes">Prevention of Primary Manifestations</a>).</p><p>Supportive treatment includes IVIG and antibacterial, antifungal, antiviral, and <i>Pneumocystis jiroveci</i> prophylaxis to control and reduce the occurrence of infections.</p></div><div id="zap70-scid.Prevention_of_Primary_Manifes"><h3>Prevention of Primary Manifestations</h3><p>The only curative therapy for <i>ZAP70</i>-related CID is allogeneic hematopoietic stem cell transplantation (HSCT). Extrapolated data show that the outcome of HSCT in children with SCID is significantly improved by performing HSCT prior to the onset of infections [<a class="bk_pop" href="#zap70-scid.REF.pai.2014.434">Pai et al 2014</a>]. Children with <i>ZAP70</i>-related CID have been successfully transplanted using a variety of donors including haploidentical donors and unrelated umbilical cord blood [<a class="bk_pop" href="#zap70-scid.REF.noraz.2000.15832">Noraz et al 2000</a>, <a class="bk_pop" href="#zap70-scid.REF.elder.2001.656">Elder et al 2001</a>, <a class="bk_pop" href="#zap70-scid.REF.h_nig.2012.305">H&#x000f6;nig et al 2012</a>, <a class="bk_pop" href="#zap70-scid.REF.cuvelier.2016.713">Cuvelier et al 2016</a>].</p><ul><li class="half_rhythm"><div>Outcomes are the best with HLA-matched, related donors.</div></li><li class="half_rhythm"><div>If an HLA-matched, related donor is not available, alternatives include:</div><ul><li class="half_rhythm"><div>Matched unrelated donor;</div></li><li class="half_rhythm"><div>Umbilical cord blood donor;</div></li><li class="half_rhythm"><div>Haploidentical parental bone marrow or mobilized peripheral blood stem cells that have been T-cell depleted.</div></li></ul></li><li class="half_rhythm"><div>In contrast to individuals with SCID, individuals with <i>ZAP70</i>-related CID are typically treated with a chemotherapeutic conditioning regimen prior to HSCT, although some individuals have received unconditioned transplants with variable success, suggesting that conditioning may not be essential in some circumstances [<a class="bk_pop" href="#zap70-scid.REF.h_nig.2012.305">H&#x000f6;nig et al 2012</a>, <a class="bk_pop" href="#zap70-scid.REF.kim.2013.1233">Kim et al 2013</a>, <a class="bk_pop" href="#zap70-scid.REF.cuvelier.2016.713">Cuvelier et al 2016</a>].</div></li><li class="half_rhythm"><div>The largest series of eight individuals with <i>ZAP70</i>-related CID who received HSCT using a variety of stem cell sources showed the following:</div><ul><li class="half_rhythm"><div>All individuals were alive at a median of 13.5 years of follow up.</div></li><li class="half_rhythm"><div>Two-thirds of the individuals who did not receive conditioning failed to have myeloid engraftment but have maintained stable mixed chimerism. In addition, three individuals who received stem cells from a matched sib did not receive conditioning prior to transplant and achieved engraftment.</div></li><li class="half_rhythm"><div>75% of individuals developed acute graft-versus-host disease (GVHD) and 50% developed chronic GVHD.</div></li><li class="half_rhythm"><div>Seven of eight individuals achieved freedom from IVIG and show evidence of class switching with resolution of dysregulated immunoglobulin production and six of the eight show evidence of antibody production to both protein and polysaccharide vaccines.</div></li><li class="half_rhythm"><div>Two individuals receiving myeloablative conditioning have developed premature ovarian failure.</div></li></ul></li><li class="half_rhythm"><div>Cellular reconstitution following HSCT takes up to one year, while restoration of humoral immunity can take significantly longer, and may not occur in some individuals.</div></li><li class="half_rhythm"><div>Complications from HSCT include graft-versus-host disease, failure to reconstitute the humoral immune compartment, graft failure over time, and post-transplant lymphoproliferative disease [<a class="bk_pop" href="#zap70-scid.REF.skodasmith.2001.329">Skoda-Smith et al 2001</a>, <a class="bk_pop" href="#zap70-scid.REF.dvorak.2008.119">Dvorak &#x00026; Cowan 2008</a>, <a class="bk_pop" href="#zap70-scid.REF.pai.2014.434">Pai et al 2014</a>].</div></li><li class="half_rhythm"><div>Affected individuals with poor humoral reconstitution are maintained on long-term immunoglobulin replacement.</div></li></ul><p>Individuals who do not undergo HSCT require close monitoring for worsening of immune function manifested by increased susceptibility to severe or opportunistic infections (see also <a href="#zap70-scid.Surveillance">Surveillance</a>). If clinical status worsens, rapid transition to HSCT should be considered.</p></div><div id="zap70-scid.Prevention_of_Secondary_Compl"><h3>Prevention of Secondary Complications</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div>Use of irradiated, leukoreduced, cytomegalovirus (CMV)-safe blood products</div></li><li class="half_rhythm"><div>Delay of immunizations until immune reconstitution</div></li><li class="half_rhythm"><div>Consideration for formula feeds in place of breast feeding until CMV status of mother is known. Caution should be taken to assess the quality of the water source for the infant formula.</div></li></ul></div><div id="zap70-scid.Surveillance"><h3>Surveillance</h3><p>Following a successful HSCT, the following should be routinely monitored:</p><ul><li class="half_rhythm"><div>Growth</div></li><li class="half_rhythm"><div>Psychomotor development</div></li><li class="half_rhythm"><div>Complete blood counts</div></li><li class="half_rhythm"><div>Liver and renal function</div></li><li class="half_rhythm"><div>Immune status</div></li><li class="half_rhythm"><div>Donor and recipient chimerism</div></li><li class="half_rhythm"><div>Development of post-transplant complications, particularly chronic graft-versus-host disease, decreased bone density, pulmonary and cardiac function, and gonadal function</div></li></ul><p>Individuals with milder findings or those who have not undergone HSCT also need to be monitored for worsening of immune function with periodic assessment of clinical status and functional lymphocyte responsiveness.</p></div><div id="zap70-scid.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Individuals with <i>ZAP70</i>-related CID should avoid the following:</p><ul><li class="half_rhythm"><div>Non-irradiated blood products</div></li><li class="half_rhythm"><div>Live virus vaccinations</div></li><li class="half_rhythm"><div><i>Mycobacterium bovis</i> (BCG) vaccine against tuberculosis, <i>Salmonella typhi</i> (Ty21a) vaccine against typhoid fever, and <i>Vibrio cholerae</i> (CVD 103-HgR) vaccine against cholera, which may be part of the routine vaccination schedule in countries where these diseases are endemic</div></li><li class="half_rhythm"><div>Contaminated water sources</div></li><li class="half_rhythm"><div>Exposure to fungus-enriched environments (e.g., construction sites, agricultural areas with active soil disruption, mulch, hay)</div></li></ul></div><div id="zap70-scid.Evaluation_of_Relatives_at_Ri"><h3>Evaluation of Relatives at Risk</h3><p>Because the outcome of HSCT in children with <i>ZAP70</i>-related CID is significantly improved by performing HSCT prior to the onset of severe infections, early testing of at-risk sibs should be considered. In addition, any sibs considered as bone marrow donors must be evaluated for <i>ZAP70</i>-related CID prior to donation.</p><ul><li class="half_rhythm"><div>If the <i>ZAP70</i> pathogenic variants in the family are known, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can be used to clarify the genetic status of at-risk sibs.</div></li><li class="half_rhythm"><div>If the pathogenic variants in the family are not known, CBC, quantitative immunoglobulins, and lymphocyte subsets and proliferation can be used to clarify the genetic status (immunologic status) of at-risk sibs.</div></li></ul><p>See <a href="#zap70-scid.Related_Genetic_Counseling_Is">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="zap70-scid.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Appropriately screened blood products should be available, if needed, during the course of the pregnancy and delivery.</p></div><div id="zap70-scid.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p><b>Gene therapy.</b> Gene therapy has not been performed in <i>ZAP70</i>-related CID. Experimental studies utilizing <a class="def" href="/books/n/gene/glossary/def-item/gene-therapy/">gene therapy</a> have been conducted on murine models [<a class="bk_pop" href="#zap70-scid.REF.adjali.2005.2287">Adjali et al 2005</a>, <a class="bk_pop" href="#zap70-scid.REF.irla.2008.e2059">Irla et al 2008</a>] as well as human cells in vitro [<a class="bk_pop" href="#zap70-scid.REF.steinberg.2000.1392">Steinberg et al 2000</a>, <a class="bk_pop" href="#zap70-scid.REF.kofler.2004.1416">Kofler et al 2004</a>, <a class="bk_pop" href="#zap70-scid.REF.gavino.2017.1688">Gavino et al 2017</a>]. Nonviral transfer methods (e.g., electro-gene transfer) have also been used to correct ZAP-70 deficiency in a murine model [<a class="bk_pop" href="#zap70-scid.REF.irla.2008.e2059">Irla et al 2008</a>].</p><p>Search <a href="http://clinicaltrials.gov" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="zap70-scid.Genetic_Counseling"><h2 id="_zap70-scid_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="zap70-scid.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>ZAP70</i>-related combined immunodeficiency (CID) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="zap70-scid.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <i>ZAP70</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes usually do not have CID-like symptoms. Parents of probands who did not appear to have clinical symptoms had intermediate expression levels compared to healthy controls [<a class="bk_pop" href="#zap70-scid.REF.turul.2009.87">Turul et al 2009</a>]. Further studies suggested a ZAP-70 protein level threshold effect, which may explain why parents with decreased <i>ZAP70</i> expression may have no clinical features [<a class="bk_pop" href="#zap70-scid.REF.cauwe.2014.377">Cauwe et al 2014</a>].</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Even if the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> are asymptomatic, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> to determine their genetic status should be considered for the purpose of early diagnosis and treatment of those who have inherited both pathogenic variants (see <a href="#zap70-scid.Evaluation_of_Relatives_at_Ri">Evaluation of Relatives at Risk</a>).</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The offspring of an individual with <i>ZAP70</i>-related CID will inherit one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li><li class="half_rhythm"><div>The genetic status of the offspring will depend on the genetic status of the reproductive partner of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div><ul><li class="half_rhythm"><div>If the reproductive partner is not <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and not a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, all offspring will be carriers.</div></li><li class="half_rhythm"><div>If the reproductive partner is a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <i>ZAP70</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, each child will have a 50% chance of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and a 50% chance of being a carrier.</div></li><li class="half_rhythm"><div>If the reproductive partner is also <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, all offspring will be affected.</div></li></ul></li></ul><p><b>Other family members.</b> A detailed family history that includes the ancestry and culture of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s family may reveal <a class="def" href="/books/n/gene/glossary/def-item/consanguinity/">consanguinity</a> and geographic and genetic isolation &#x02013; risk factors that increase the likelihood of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> diseases in a family. Some of the grandparents of the proband are carriers of a <i>ZAP70</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; therefore, sibs of the proband's parents and their offspring are at risk of being carriers.</p></div><div id="zap70-scid.Carrier_Heterozygote_Detectio"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>ZAP70</i> pathogenic variants in the family.</p></div><div id="zap70-scid.Related_Genetic_Counseling_Is"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#zap70-scid.Evaluation_of_Relatives_at_Ri">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="zap70-scid.Prenatal_Testing_and_Preimpla"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>ZAP70</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for <i>ZAP70</i>-related CID are possible.</p><p>An <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> fetus does not require any specific management prior to delivery. Following delivery, early evaluation for potential HSCT should be performed because of the known benefit of early HSCT (see <a href="#zap70-scid.Evaluation_of_Relatives_at_Ri">Evaluation of Relatives at Risk</a>).</p></div></div><div id="zap70-scid.Resources"><h2 id="_zap70-scid_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>International Patient Organisation for Primary Immunodeficiencies (IPOPI)</b></div><div>Firside</div><div>Main Road</div><div>Downderry Cornwall PL11 3LE</div><div>United Kingdom</div><div><b>Phone:</b> +44 01503 250 668</div><div><b>Fax:</b> +44 01503 250 668</div><div><b>Email:</b> info@ipopi.org</div><div><a href="http://ipopi.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ipopi.org</a></div></li><li class="half_rhythm"><div><b>Jeffrey Modell Foundation/National Primary Immunodeficiency Resource Center</b></div><div>747 Third Avenue</div><div>New York NY 10017</div><div><b>Phone:</b> 866-463-6474 (toll-free); 212-819-0200</div><div><b>Fax:</b> 212-764-4180</div><div><b>Email:</b> info@jmfworld.org</div><div><a href="http://www.info4pi.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.info4pi.org</a></div></li><li class="half_rhythm"><div><b>Canadian Immunodeficiencies Patient Organization (CIPO)</b></div><div>362 Concession Road 12</div><div>RR #2</div><div>Hastings Ontario K0L 1Y0</div><div>Canada</div><div><b>Phone:</b> 877-262-2476 (toll-free)</div><div><b>Fax:</b> 866-942-7651 (toll-free)</div><div><b>Email:</b> info@cipo.ca</div><div><a href="http://cipo.ca" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.cipo.ca</a></div></li><li class="half_rhythm"><div><b>National Human Genome Research Institute (NHGRI)</b></div><div><a href="http://www.genome.gov/13014325" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Learning About Severe Combined Immunodeficiency (SCID)</a></div></li><li class="half_rhythm"><div><b>NCBI Genes and Disease</b></div><div><a href="/books/NBK22254/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Severe combined immunodeficiency</a></div></li><li class="half_rhythm"><div><b>European Society for Immunodeficiencies (ESID) Registry</b></div><div>Dr. Gerhard Kindle</div><div>University Medical Center Freiburg Centre of Chronic Immunodeficiency</div><div>Engesserstr. 4</div><div>79106 Freiburg </div><div>Germany</div><div><b>Phone:</b> 49-761-270-34450</div><div><b>Email:</b> esid-registry@uniklinik-freiburg.de</div><div><a href="http://esid.org/Working-Parties/Registry" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ESID Registry</a></div></li><li class="half_rhythm"><div><b>Primary Immunodeficiency Diseases Registry at USIDNET</b></div><div>40 West Chesapeake Avenue</div><div>Suite 308</div><div>Towson MD 21204-4803</div><div><b>Phone:</b> 866-939-7568</div><div><b>Fax:</b> 410-321-0293</div><div><b>Email:</b> contact@usidnet.org</div><div><a href="http://usidnet.org/usidnet-registry/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Primary Immunodeficiency Registry at USIDNET</a></div></li><li class="half_rhythm"><div><b>RDCRN Patient Contact Registry: Primary Immune Deficiency Treatment Consortium</b></div><div><a href="https://www.rarediseasesnetwork.org/cms/pidtc" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Patient Contact Registry</a></div></li></ul></div><div id="zap70-scid.Molecular_Genetics"><h2 id="_zap70-scid_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="zap70-scid.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>ZAP70-Related Combined Immunodeficiency: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK20221/table/zap70-scid.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__zap70-scid.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_zap70-scid.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_zap70-scid.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_zap70-scid.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_zap70-scid.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_zap70-scid.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_zap70-scid.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_zap70-scid.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/7535" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ZAP70</i></a></td><td headers="hd_b_zap70-scid.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=7535" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">2q11<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_zap70-scid.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P43403" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Tyrosine-protein kinase ZAP-70</a></td><td headers="hd_b_zap70-scid.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/ZAP70" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ZAP70 database</a><br /><a href="http://structure.bmc.lu.se/idbase/ZAP70base/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ZAP70base: Mutation registry for autosomal recessive ZAP70 immunodeficiency</a></td><td headers="hd_b_zap70-scid.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ZAP70" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ZAP70</a></td><td headers="hd_b_zap70-scid.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ZAP70[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ZAP70</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="zap70-scid.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="zap70-scid.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for ZAP70-Related Combined Immunodeficiency (<a href="/omim/176947,269840" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK20221/table/zap70-scid.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__zap70-scid.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/176947" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">176947</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ZETA-CHAIN-ASSOCIATED PROTEIN KINASE; ZAP70</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/269840" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">269840</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">IMMUNODEFICIENCY 48; IMD48</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>ZAP70</i> spans 26.3 kb of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. The <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> consists of 14 exons comprising 2450 bp. For a detailed summary of gene and protein information, see <a href="/books/NBK20221/#zap70-scid.molgen.TA">Table A</a>.</p><p><b>Pathogenic variants.</b>
<i>ZAP70</i> pathogenic variants reside mostly in the kinase <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, although pathogenic variants that result in loss of transcription or are located in the N-terminal SH2 domain and result in rapid degradation of ZAP-70 protein have been reported [<a class="bk_pop" href="#zap70-scid.REF.matsuda.1999.34515">Matsuda et al 1999</a>, <a class="bk_pop" href="#zap70-scid.REF.auyeung.2009.41">Au-Yeung et al 2009</a>]. More than 20 pathogenic variants including single-nucleotide variants, splice defects, and intragenic deletions have been reported. A <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the arginine residue (p.Arg465Cys) of the DLAARN motif of the kinase domain has been described (see <b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a></b>).</p><div id="zap70-scid.T.zap70_pathogenic_variants_d" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p><i>ZAP70</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK20221/table/zap70-scid.T.zap70_pathogenic_variants_d/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__zap70-scid.T.zap70_pathogenic_variants_d_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_zap70-scid.T.zap70_pathogenic_variants_d_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_zap70-scid.T.zap70_pathogenic_variants_d_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_zap70-scid.T.zap70_pathogenic_variants_d_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_zap70-scid.T.zap70_pathogenic_variants_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.239C&#x0003e;A<br />(448C&#x0003e;A)</td><td headers="hd_h_zap70-scid.T.zap70_pathogenic_variants_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro80Gln</td><td headers="hd_h_zap70-scid.T.zap70_pathogenic_variants_d_1_1_1_3" rowspan="8" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nucleotide/46488942" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001079<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/31455611" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001070<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_zap70-scid.T.zap70_pathogenic_variants_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.574C&#x0003e;T</td><td headers="hd_h_zap70-scid.T.zap70_pathogenic_variants_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg192Trp</td></tr><tr><td headers="hd_h_zap70-scid.T.zap70_pathogenic_variants_d_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.837+121G&#x0003e;A<br />(836+121G&#x0003e;A)</td><td headers="hd_h_zap70-scid.T.zap70_pathogenic_variants_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_zap70-scid.T.zap70_pathogenic_variants_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1079G&#x0003e;C</td><td headers="hd_h_zap70-scid.T.zap70_pathogenic_variants_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg360Pro</td></tr><tr><td headers="hd_h_zap70-scid.T.zap70_pathogenic_variants_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1272C&#x0003e;T</td><td headers="hd_h_zap70-scid.T.zap70_pathogenic_variants_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 2</td></tr><tr><td headers="hd_h_zap70-scid.T.zap70_pathogenic_variants_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1393C&#x0003e;T</td><td headers="hd_h_zap70-scid.T.zap70_pathogenic_variants_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg465Cys</td></tr><tr><td headers="hd_h_zap70-scid.T.zap70_pathogenic_variants_d_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1624-11G&#x0003e;A</td><td headers="hd_h_zap70-scid.T.zap70_pathogenic_variants_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_zap70-scid.T.zap70_pathogenic_variants_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1714A&#x0003e;T<br />(1923A&#x0003e;T)</td><td headers="hd_h_zap70-scid.T.zap70_pathogenic_variants_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met572Leu</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. GeneReviews staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: GeneReviews follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="zap70-scid.TF.4.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd><dt>2. </dt><dd><div id="zap70-scid.TF.4.2"><p class="no_margin">The variant is predicted to be silent (p.Gly355=) but has been demonstrated to result in a <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> defect [<a class="bk_pop" href="#zap70-scid.REF.gavino.2017.1688">Gavino et al 2017</a>].</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>ZAP70</i> codes for a 619-amino acid enzyme, ZAP-70, that contains two SH2 domains and one kinase <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>. This Syk-protein tyrosine kinase family member plays a role in T cell development and activation. ZAP-70 directly interacts with the T-cell receptor (TCR) complex and is phosphorylated at tyrosine residues upon TCR stimulation, functioning in the initial step of TCR-mediated signal transduction with Src family kinases.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Most pathogenic variants affect the kinase <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of <i>ZAP70</i> and cause a lack of or severely decreased protein expression. Loss of ZAP-70 activity leads to lack of signaling through the T-cell receptor and subsequent defects in CD8+ cell development and in global T-cell function [<a class="bk_pop" href="#zap70-scid.REF.fischer.2010.107">Fischer et al 2010</a>].</p><p>The residual function seen in CD4 and CD8 cells in individuals lacking ZAP-70 may be related to increased expression of Syk in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> cells [<a class="bk_pop" href="#zap70-scid.REF.hauck.2015.103">Hauck et al 2015</a>]. In ZAP-70-deficient CD4+ cells, TCR stimulation was able to induce antigen-specific IgE responses in B cells in part via increased expression of Syk [<a class="bk_pop" href="#zap70-scid.REF.toyabe.2001.164">Toyabe et al 2001</a>].</p></div><div id="zap70-scid.References"><h2 id="_zap70-scid_References_">References</h2><div id="zap70-scid.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.adjali.2005.2287">Adjali O, Marodon G, Steinberg M, Mongellaz C, Thomas-Vaslin V, Jacquet C, Taylor N, Klatzmann D. In vivo correction of ZAP-70 immunodeficiency by intrathymic gene transfer. <span><span class="ref-journal">J Clin Invest. </span>2005;<span class="ref-vol">115</span>:2287–95.</span> [<a href="/pmc/articles/PMC1180533/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1180533</span></a>] [<a href="/pubmed/16075064" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16075064</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.akar.2015.88">Akar HH, Patiroglu T, Akyildiz BN, Tekerek NU, Do&#x0011f;an MS, Do&#x0011f;anay S, van der Burg M, Dusunsel R. Silent brain infarcts in two patients with zeta chain-associated protein 70 kDa (ZAP70) deficiency. <span><span class="ref-journal">Clin Immunol. </span>2015;<span class="ref-vol">158</span>:88–91.</span> [<a href="/pubmed/25805655" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25805655</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.aluri.2017.95">Aluri J, Italia K, Gupta M, Dalvi A, Bavdekar A, Madkaikar M. Low T cell receptor excision circles (TRECs) in a case of ZAP 70 deficient severe combined immunodeficiency (SCID) with a novel mutation from India. <span><span class="ref-journal">Blood Cells Mol Dis. </span>2017;<span class="ref-vol">65</span>:95–6.</span> [<a href="/pubmed/27839984" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27839984</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.arpaia.1994.947">Arpaia E, Shahar M, Dadi H, Cohen A, Roifman CM. Defective T cell receptor signaling and CD8+ thymic selection in humans lacking zap-70 kinase. <span><span class="ref-journal">Cell. </span>1994;<span class="ref-vol">76</span>:947–58.</span> [<a href="/pubmed/8124727" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8124727</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.auyeung.2009.41">Au-Yeung BB, Deindl S, Hsu LY, Palacios EH, Levin SE, Kuriyan J, Weiss A. The structure, regulation, and function of ZAP-70. <span><span class="ref-journal">Immunol Rev. </span>2009;<span class="ref-vol">228</span>:41–57.</span> [<a href="/pubmed/19290920" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19290920</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.barata.2001.413">Barata LT, Henriques R, Hivroz C, Jouanguy E, Paiva A, Freitas AM, Coimbra HB, Fischer A, da Mota HC. <span><span class="ref-journal">Acta Med Port. </span>2001;<span class="ref-vol">14</span>:413–7.</span> [Primary immunodeficiency secondary to ZAP-70 deficiency] [<a href="/pubmed/11762183" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11762183</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.cauwe.2014.377">Cauwe B, Tian L, Franckaert D, Pierson W, Staats KA, Schlenner SM, Liston A. A novel Zap70 mutation with reduced protein stability demonstrates the rate-limiting threshold for Zap70 in T-cell receptor signalling. <span><span class="ref-journal">Immunology. </span>2014;<span class="ref-vol">141</span>:377–87.</span> [<a href="/pmc/articles/PMC3930376/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3930376</span></a>] [<a href="/pubmed/24164480" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24164480</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.chan.1994.1599">Chan AC, Kadlecek TA, Elder ME, Filipovich AH, Kuo WL, Iwashima M, Parslow TG, Weiss A. ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency. <span><span class="ref-journal">Science. </span>1994;<span class="ref-vol">264</span>:1599–601.</span> [<a href="/pubmed/8202713" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8202713</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.chan.2016.155">Chan AY, Punwani D, Kadlecek TA, Cowan MJ, Olson JL, Mathes EF, Sunderam U, Fu SM, Srinivasan R, Kuriyan J, Brenner SE, Weiss A, Puck JM. A novel human autoimmune syndrome caused by combined hypomorphic and activating mutations in ZAP-70. <span><span class="ref-journal">J Exp Med. </span>2016;<span class="ref-vol">213</span>:155–65.</span> [<a href="/pmc/articles/PMC4749924/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4749924</span></a>] [<a href="/pubmed/26783323" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26783323</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.cuvelier.2016.713">Cuvelier GD, Rubin TS, Wall DA, Schroeder ML. Long-term outcomes of hematopoietic stem cell transplantation for ZAP70 deficiency. <span><span class="ref-journal">J Clin Immunol. </span>2016;<span class="ref-vol">36</span>:713–24.</span> [<a href="/pubmed/27438785" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27438785</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.de_la_callemartin.2001.117">de la Calle-Martin O, Hernandez M, Ordi J, Casamitjana N, Arostegui JI, Caragol I, Ferrando M, Labrador M, Rodriguez-Sanchez JL, Espanol T. Familial CD8 deficiency due to a mutation in the CD8 alpha gene. <span><span class="ref-journal">J Clin Invest. </span>2001;<span class="ref-vol">108</span>:117–23.</span> [<a href="/pmc/articles/PMC209336/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC209336</span></a>] [<a href="/pubmed/11435463" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11435463</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.dvorak.2008.119">Dvorak CC, Cowan MJ. Hematopoietic stem cell transplantation for primary immunodeficiency disease. <span><span class="ref-journal">Bone Marrow Transplant. </span>2008;<span class="ref-vol">41</span>:119–26.</span> [<a href="/pubmed/17968328" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17968328</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.elder.1997.546">Elder ME. SCID due to ZAP-70 deficiency. <span><span class="ref-journal">J Pediatr Hematol Oncol. </span>1997;<span class="ref-vol">19</span>:546–50.</span> [<a href="/pubmed/9407944" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9407944</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.elder.1995.110">Elder ME, Hope TJ, Parslow TG, Umetsu DT, Wara DW, Cowan MJ. Severe combined immunodeficiency with absence of peripheral blood CD8+ T cells due to ZAP-70 deficiency. <span><span class="ref-journal">Cell Immunol. </span>1995;<span class="ref-vol">165</span>:110–7.</span> [<a href="/pubmed/7671314" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7671314</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.elder.1994.1596">Elder ME, Lin D, Clever J, Chan AC, Hope TJ, Weiss A, Parslow TG. Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase. <span><span class="ref-journal">Science. </span>1994;<span class="ref-vol">264</span>:1596–9.</span> [<a href="/pubmed/8202712" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8202712</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.elder.2001.656">Elder ME, Skoda-Smith S, Kadlecek TA, Wang F, Wu J, Weiss A. Distinct T cell developmental consequences in humans and mice expressing identical mutations in the DLAARN motif of ZAP-70. <span><span class="ref-journal">J Immunol. </span>2001;<span class="ref-vol">166</span>:656–61.</span> [<a href="/pubmed/11123350" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11123350</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.esenboga.2016.103">Esenboga S, Ayvaz DC, Cetinkaya PG, van der Burg M, Tezcan I. An infant with ZAP-70 deficiency with disseminated mycobacterial disease. <span><span class="ref-journal">J Clin Immunol. </span>2016;<span class="ref-vol">36</span>:103–6.</span> [<a href="/pubmed/26707786" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26707786</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.fagioli.2003.133">Fagioli F, Biasin E, Berger M, Nesi F, Saroglia EH, Miniero R, Martino S, Tovo PA. Successful unrelated cord blood transplantation in two children with severe combined immunodeficiency syndrome. <span><span class="ref-journal">Bone Marrow Transplant. </span>2003;<span class="ref-vol">31</span>:133–6.</span> [<a href="/pubmed/12621496" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12621496</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.fischer.2010.107">Fischer A, Picard C, Chemin K, Dogniaux S, le Deist F, Hivroz C. ZAP70: a master regulator of adaptive immunity. <span><span class="ref-journal">Semin Immunopathol. </span>2010;<span class="ref-vol">32</span>:107–16.</span> [<a href="/pubmed/20135127" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20135127</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.gavino.2017.1688">Gavino C, Landekic M, Zeng J, Wu N, Jung S, Zhong MC, Cohen-Blanchet A, Langelier M, Neyret O, Lejtenyi D, Rochefort C, Cotton-Montpetit J, McCusker C, Mazer B, Veillette A, Vinh DC. Morpholino-based correction of hypomorphic ZAP70 mutation in an adult with combined immunodeficiency. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2017;<span class="ref-vol">139</span>:1688–92.e10.</span> [<a href="/pubmed/28216435" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28216435</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.gelfand.1995.1057">Gelfand EW, Weinberg K, Mazer BD, Kadlecek TA, Weiss A. Absence of ZAP-70 prevents signaling through the antigen receptor on peripheral blood T cells but not on thymocytes. <span><span class="ref-journal">J Exp Med. </span>1995;<span class="ref-vol">182</span>:1057–65.</span> [<a href="/pmc/articles/PMC2192291/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2192291</span></a>] [<a href="/pubmed/7561679" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7561679</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.grazioli.2014.209">Grazioli S, Bennett M, Hildebrand KJ, Vallance H, Turvey SE, Junker AK. Limitation of TREC-based newborn screening for ZAP70 Severe Combined Immunodeficiency. <span><span class="ref-journal">Clin Immunol. </span>2014;<span class="ref-vol">153</span>:209–10.</span> [<a href="/pubmed/24797280" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24797280</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.hauck.2015.103">Hauck F, Blumenthal B, Fuchs S, Lenoir C, Martin E, Speckmann C, Vraetz T, Mannhardt-Laakmann W, Lambert N, Gil M, Borte S, Audrain M, Schwarz K, Lim A, Schamel WW, Fischer A, Ehl S, Rensing-Ehl A, Picard C, Latour S. SYK expression endows human ZAP70-deficient CD8 T cells with residual TCR signaling. <span><span class="ref-journal">Clin Immunol. </span>2015;<span class="ref-vol">161</span>:103–9.</span> [<a href="/pubmed/26187144" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26187144</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.h_nig.2012.305">H&#x000f6;nig M, Schuetz C, Schwarz K, Rojewski M, Jacobsen E, Lahr G, Debatin KM, Schulz A, Friedrich W. Immunological reconstitution in a patient with ZAP-70 deficiency following transfusion of blood lymphocytes from a previously transplanted sibling without conditioning. <span><span class="ref-journal">Bone Marrow Transplant. </span>2012;<span class="ref-vol">47</span>:305–7.</span> [<a href="/pubmed/21441961" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21441961</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.irla.2008.e2059">Irla M, Saade M, Kissenpfennig A, Poulin LF, Leserman L, Marche PN, Jouvin-Marche E, Berger F, Nguyen C. ZAP-70 restoration in mice by in vivo thymic electroporation. <span><span class="ref-journal">PloS One. </span>2008;<span class="ref-vol">3</span>:e2059.</span> [<a href="/pmc/articles/PMC2323614/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2323614</span></a>] [<a href="/pubmed/18446234" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18446234</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.jilkina.2014.324">Jilkina O, Thompson JR, Kwan L, Van Caeseele P, Rockman-Greenberg C, Schroeder ML. Retrospective TREC testing of newborns with Severe Combined Immunodeficiency and other primary immunodeficiency diseases. <span><span class="ref-journal">Mol Genet Metab Rep. </span>2014;<span class="ref-vol">1</span>:324–33.</span> [<a href="/pmc/articles/PMC5121305/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5121305</span></a>] [<a href="/pubmed/27896105" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27896105</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.karaca.2013.189">Karaca E, Karakoc-Aydiner E, Bayrak OF, Keles S, Sevli S, Barlan IB, et al.  Identification of a novel mutation in ZAP70 and prenatal diagnosis in a Turkish family with severe combined immunodeficiency disorder. <span><span class="ref-journal">Gene. </span>2013;<span class="ref-vol">512</span>:189–93.</span> [<a href="/pubmed/23124046" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23124046</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.katamura.1999.124">Katamura K, Tai G, Tachibana T, Yamabe H, Ohmori K, Mayumi M, Yuksel A, Chatila TA, Ozen M. Existence of activated and memory CD4+ T cells in peripheral blood and their skin infiltration in CD8 deficiency. <span><span class="ref-journal">Clin Exp Immunol. </span>1999;<span class="ref-vol">115</span>:124–30.</span> [<a href="/pmc/articles/PMC1905204/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1905204</span></a>] [<a href="/pubmed/9933431" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9933431</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.kim.2013.1233">Kim VH, Murguia L, Schechter T, Grunebaum E, Roifman CM. Emergency treatment for zeta chain-associated protein of 70 kDa (ZAP70) deficiency. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2013;<span class="ref-vol">131</span>:1233–5.</span> [<a href="/pubmed/23141738" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23141738</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.kofler.2004.1416">Kofler DM, Buning H, Mayr C, Bund D, Baumert J, Hallek M, Wendtner CM. Engagement of the B-cell antigen receptor (BCR) allows efficient transduction of ZAP-70-positive primary B-CLL cells by recombinant adeno-associated virus (rAAV) vectors. <span><span class="ref-journal">Gene Ther. </span>2004;<span class="ref-vol">11</span>:1416–24.</span> [<a href="/pubmed/15269708" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15269708</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.mancebo.2008.479">Mancebo E, Moreno-Pelayo MA, Menc&#x000ed;a A, de la Calle-Mart&#x000ed;n O, Allende LM, Sivadorai P, Kalaydjieva L, Bertranpetit J, Coto E, Calleja-Antol&#x000ed;n S, Ruiz-Contreras J, Paz-Artal E. Gly111Ser mutation in CD8A gene causing CD8 immunodeficiency is found in Spanish Gypsies. <span><span class="ref-journal">Mol Immunol. </span>2008;<span class="ref-vol">45</span>:479–84.</span> [<a href="/pubmed/17658607" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17658607</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.matsuda.1999.34515">Matsuda S, Suzuki-Fujimoto T, Minowa A, Ueno H, Katamura K, Koyasu S. Temperature-sensitive ZAP70 mutants degrading through a proteasome-independent pathway. Restoration of a kinase domain mutant by Cdc37. <span><span class="ref-journal">J Biol Chem. </span>1999;<span class="ref-vol">274</span>:34515–8.</span> [<a href="/pubmed/10574909" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10574909</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.meinl.2000.3578">Meinl E, Lengenfelder D, Blank N, Pirzer R, Barata L, Hivroz C. Differential requirement of ZAP-70 for CD2-mediated activation pathways of mature human T cells. <span><span class="ref-journal">J Immunol. </span>2000;<span class="ref-vol">165</span>:3578–83.</span> [<a href="/pubmed/11034358" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11034358</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.newell.2011.517">Newell A, Dadi H, Goldberg R, Ngan BY, Grunebaum E, Roifman CM. Diffuse large B-cell lymphoma as presenting feature of Zap-70 deficiency. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2011;<span class="ref-vol">127</span>:517–20.</span> [<a href="/pubmed/21094993" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21094993</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.noraz.2000.15832">Noraz N, Schwarz K, Steinberg M, Dardalhon V, Rebouissou C, Hipskind R, Friedrich W, Yssel H, Bacon K, Taylor N. Alternative antigen receptor (TCR) signaling in T cells derived from ZAP-70-deficient patients expressing high levels of Syk. <span><span class="ref-journal">J Biol Chem. </span>2000;<span class="ref-vol">275</span>:15832–8.</span> [<a href="/pubmed/10748099" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10748099</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.pai.2014.434">Pai SY, Logan BR, Griffith LM, Buckley RH, Parrott RE, Dvorak CC, Kapoor N, Hanson IC, Filipovich AH, Jyonouchi S, Sullivan KE, Small TN, Burroughs L, Skoda-Smith S, Haight AE, Grizzle A, Pulsipher MA, Chan KW, Fuleihan RL, Haddad E, Loechelt B, Aquino VM, Gillio A, Davis J, Knutsen A, Smith AR, Moore TB, Schroeder ML, Goldman FD, Connelly JA, Porteus MH, Xiang Q, Shearer WT, Fleisher TA, Kohn DB, Puck JM, Notarangelo LD, Cowan MJ, O'Reilly RJ. Transplantation outcomes for severe combined immunodeficiency, 2000-2009. <span><span class="ref-journal">N Engl J Med. </span>2014;<span class="ref-vol">371</span>:434–46.</span> [<a href="/pmc/articles/PMC4183064/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4183064</span></a>] [<a href="/pubmed/25075835" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25075835</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.picard.2009.1966">Picard C, Dogniaux S, Chemin K, Maciorowski Z, Lim A, Mazerolles F, Rieux-Laucat F, Stolzenberg MC, Debre M, Magny JP, Le Deist F, Fischer A, Hivroz C. Hypomorphic mutation of ZAP70 in human results in a late onset immunodeficiency and no autoimmunity. <span><span class="ref-journal">Eur J Immunol. </span>2009;2009;<span class="ref-vol">39</span>:1966–76.</span> [<a href="/pubmed/19548248" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19548248</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.poliani.2013">Poliani PL, Fontana E, Roifman CM, Notarangelo LD (2013) Zeta chain-associated protein of 70 kDa (ZAP70) deficiency in human subjects is associated with abnormalities of thymic stromal cells: Implications for T-cell tolerance. J Allergy Clin Immunol. 131:597-600.e591-2. [<a href="/pubmed/23245794" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23245794</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.roifman.2010.1226">Roifman CM, Dadi H, Somech R, Nahum A, Sharfe N. Characterization of zeta-associated protein, 70 kd (ZAP70)-deficient human lymphocytes. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2010;<span class="ref-vol">126</span>:1226–33.e1.</span> [<a href="/pubmed/20864151" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20864151</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.roifman.2012.177">Roifman CM, Somech R, Kavadas F, Pires L, Nahum A, Dalal I, Grunebaum E. Defining combined immunodeficiency. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2012;<span class="ref-vol">130</span>:177–83.</span> [<a href="/pubmed/22664165" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22664165</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.santos.2010.530">Santos A, Dias A, Cordeiro A, Cordinha C, Lemos S, Rocha G, Faria E. Severe axillary lymphadenitis after BCG vaccination: alert for primary immunodeficiencies. <span><span class="ref-journal">J Microbiol Immunol Infect. </span>2010;<span class="ref-vol">43</span>:530–7.</span> [<a href="/pubmed/21195982" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21195982</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.schroeder.2016.50">Schroeder ML, Triggs-Raine B, Zelinski T. Genotyping an immunodeficiency causing c.1624-11G&#x0003e;A ZAP70 mutation in Canadian Mennonites. <span><span class="ref-journal">BMC Med Genet. </span>2016;<span class="ref-vol">17</span>:50.</span> [<a href="/pmc/articles/PMC4957335/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4957335</span></a>] [<a href="/pubmed/27448562" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27448562</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.shirkani.2017.70">Shirkani A, Shahrooei M, Azizi G, Rokni-Zadeh H, Abolhassani H, Farrokhi S, Frans G, Bossuyt X, Aghamohammadi A. Novel mutation of ZAP-70-related combined immunodeficiency: first case from the National Iranian Registry and review of the literature. <span><span class="ref-journal">Immunol Invest. </span>2017;<span class="ref-vol">46</span>:70–9.</span> [<a href="/pubmed/27759478" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27759478</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.skodasmith.2001.329">Skoda-Smith S, Douglas VK, Mehta P, Graham-Pole J, Wingard JR. Treatment of post-transplant lymphoproliferative disease with induction chemotherapy followed by haploidentical peripheral blood stem cell transplantation and Rituximab. <span><span class="ref-journal">Bone Marrow Transplant. </span>2001;<span class="ref-vol">27</span>:329–32.</span> [<a href="/pubmed/11277182" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11277182</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.steinberg.2000.1392">Steinberg M, Swainson L, Schwarz K, Boyer M, Friedrich W, Yssel H, Taylor N, Noraz N. Retrovirus-mediated transduction of primary ZAP-70-deficient human T cells results in the selective growth advantage of gene-corrected cells: implications for gene therapy. <span><span class="ref-journal">Gene Ther. </span>2000;<span class="ref-vol">7</span>:1392–400.</span> [<a href="/pubmed/10981666" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10981666</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.toyabe.2001.164">Toyabe S, Watanabe A, Harada W, Karasawa T, Uchiyama M. Specific immunoglobulin E responses in ZAP-70-deficient patients are mediated by Syk-dependent T-cell receptor signalling. <span><span class="ref-journal">Immunology. </span>2001;<span class="ref-vol">103</span>:164–71.</span> [<a href="/pmc/articles/PMC1783225/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1783225</span></a>] [<a href="/pubmed/11412303" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11412303</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="zap70-scid.REF.turul.2009.87">Turul T, Tezcan I, Artac H, de Bruin-Versteeg S, Barendregt BH, Reisli I, Sanal O, van Dongen JJ, van der Burg M. Clinical heterogeneity can hamper the diagnosis of patients with ZAP70 deficiency. <span><span class="ref-journal">Eur J Pediatr. </span>2009;<span class="ref-vol">168</span>:87–93.</span> [<a href="/pubmed/18509675" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18509675</span></a>]</div></li></ul></div></div><div id="zap70-scid.Chapter_Notes"><h2 id="_zap70-scid_Chapter_Notes_">Chapter Notes</h2><div id="zap70-scid.Author_History"><h3>Author History</h3><p>Tara Capece, MPH; University of Pittsburgh (2009-2012)<br />Marc Ikeda, MD; Children's Hospital of Pittsburgh (2012-2014)<br />Allyson Larkin, MD; Children's Hospital of Pittsburgh (2012-2017)<br />David Nash, MD; Children's Hospital of Pittsburgh (2009-2012)<br />Stacy Lyn Rosenberg, MD; Children's Hospital of Pittsburgh (2014-2017)<br />Mark Vander Lugt, MD (2017-present)<br />Kelly Walkovich, MD (2017-present)</p></div><div id="zap70-scid.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>8 June 2017 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>25 September 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>6 September 2012 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> available clinically</div></li><li class="half_rhythm"><div>1 March 2012 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>20 October 2009 (me) Review posted live</div></li><li class="half_rhythm"><div>1 June 2009 (tc) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK20221</span><span class="label">PMID: <a href="/pubmed/20301777" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301777</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/yci/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/pbd/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK20221&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK20221/?report=reader">PubReader</a></li><li><a href="/books/NBK20221/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK20221" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK20221" style="display:none" title="Cite this Page"><div class="bk_tt">Walkovich K, Vander Lugt M. ZAP70-Related Combined Immunodeficiency. 2009 Oct 20 [Updated 2017 Jun 8]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK20221/pdf/Bookshelf_NBK20221.pdf">PDF version of this page</a> (485K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#zap70-scid.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#zap70-scid.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#zap70-scid.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#zap70-scid.Genetically_Related_Allelic_D" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#zap70-scid.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#zap70-scid.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#zap70-scid.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#zap70-scid.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#zap70-scid.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#zap70-scid.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#zap70-scid.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=7535[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ZAP70</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK20221+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1859948" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1859948" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1859948" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1859948" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301584" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> X-Linked Severe Combined Immunodeficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> X-Linked Severe Combined Immunodeficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Allenspach E, Rawlings DJ, Scharenberg AM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301656" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Adenosine Deaminase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Adenosine Deaminase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Hershfield M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301575" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Fanconi Anemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Fanconi Anemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mehta PA, Tolar J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301448" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hepatic Veno-Occlusive Disease with Immunodeficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hepatic Veno-Occlusive Disease with Immunodeficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Roscioli T, Ziegler JB, Buckley M, Wong M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301341" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mucopolysaccharidosis Type I</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mucopolysaccharidosis Type I<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Clarke LA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301777" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301777" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0411d875f66d18aae9ba8e">ZAP70-Related Combined Immunodeficiency - GeneReviews®</a><div class="ralinkpop offscreen_noflow">ZAP70-Related Combined Immunodeficiency - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:50:16-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8B8FB8E04104310000000000B10038&amp;ncbi_session=CE8B8FB8E0411D81_0177SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK20221%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK20221&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK20221/&amp;ncbi_pagename=ZAP70-Related Combined Immunodeficiency - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8B8FB8E0411D81_0177SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>